CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer

INTRODUCTION: As a highly aggressive tumor with a poor prognosis, esophageal cancer (ESCA)’s relationship with gene mutations is unclear. Therefore, we tried to explore the role of gene mutation in ESCA progression and its relationship with immune response, clinical treatment, and prognosis. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Xin, Song, Jianxiong, Fan, Yating, Li, Jiaqi, Chen, Yutao, Zhu, Huanhuan, Zhang, Zhiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627272/
https://www.ncbi.nlm.nih.gov/pubmed/34849012
http://dx.doi.org/10.2147/IJGM.S338284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627272/
https://www.ncbi.nlm.nih.gov/pubmed/34849012
http://dx.doi.org/10.2147/IJGM.S338284

Ejemplares similares